Diabetes drug shows promise for weight loss in new study
NCT ID NCT07367555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a common diabetes medication (SGLT-2 inhibitor) can help people with type 2 diabetes lose weight. 360 participants took the pill daily for 3 months, and researchers measured changes in body mass index (BMI). The goal was to see if the drug could help control weight as well as blood sugar.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMH Multan
Multan, Punjab Province, 60010, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sugar syrup may make colonoscopy prep safer and more effective for diabetics
- Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
- Could vinegar and fasting fix prediabetes cholesterol?
- Diabetes drug shows promise for repairing damaged nerves
- Foot flex could tame cholesterol and blood sugar
- Mass screening aims to catch silent killers early in pakistan